In India, only 1% to 8% of breast cancer patients are diagnosed in the early, stage 1 period of the disease, compared with 60% to 70% in the United States.
NIRAMAI Health Analytix, a startup technology company based in India, has developed a hand-held device to screen for breast cancer. It’s just one example of a company leveraging technology to bring affordable health care solutions to women in emerging markets, where the high costs of medical equipment have previously kept these services out of reach.
The company is one of four winners of the Global Women’s HealthTech Awards, organized by the World Bank Group and Consumer Technology Association to recognize “innovative startups that leverage tech to improve women's health and safety in emerging markets.”
About the author
Catherine Cheneycatherinecheney
Catherine Cheney is the Senior Editor for Special Coverage at Devex. She leads the editorial vision of Devex’s news events and editorial coverage of key moments on the global development calendar. Catherine joined Devex as a reporter, focusing on technology and innovation in making progress on the Sustainable Development Goals. Prior to joining Devex, Catherine earned her bachelor’s and master’s degrees from Yale University, and worked as a web producer for POLITICO, a reporter for World Politics Review, and special projects editor at NationSwell. She has reported domestically and internationally for outlets including The Atlantic and the Washington Post. Catherine also works for the Solutions Journalism Network, a non profit organization that supports journalists and news organizations to report on responses to problems.
